News Ultragenyx gets FDA nod for first Sanfilippo A gene therapy Patients in the US with Sanfilippo syndrome type A have their first FDA-approved therapy, Ultragenyx Pharma's $3.9m one-shot gene therapy Fayuvi.
News Which biotechs have raised new VC financing this week? This week's biggest biotech venture financings include sizeable rounds for Sling Therapeutics, Circle Pharma, and RegCell.
News Bavarian Nordic has found its new CEO Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.
News Bayer's Kerendia gets broader use in diabetic kidney disease Bayer's fast-growing Kerendia has had its label extended in the US to include chronic kidney disease associated with type 1 diabetes.
News NICE finally backs Enhertu for HER2-low breast cancer Almost three years after Enhertu was made available in Scotland, the drug is finally an option for patients in England with HER2-low breast cancer.
News Boehringer launches hub for patient experience data Boehringer Ingelheim has launched a hub to help patient organisations gather and use patient experience data (PED) more effectively.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.